Marina Biotech, well known for its developmental and innovative projects dealing with nucleic acid-based drugs, has announced the initiation of phase 1 clinical trials of MRX34 by its licensee, Mirna Therapeutics.
http://bionews-tx.com/news/2013/05/15/marina-biotech-licensee-mirna-therapeutics-reports-initiation-of-cprit-funded-phase-1-clinical-trial-of-anticancer-drug-mrx34/
Showing posts with label MRX34. Show all posts
Showing posts with label MRX34. Show all posts
Wednesday, May 15, 2013
Wednesday, January 23, 2013
Austin, Texas Biotech Company Mirna Thereaputics To Present Preclinical Data For Cancer Treatment At Keystone Conference
Mirna Theraputics, an innovative Texas biotech company in Austin, Texas, will present data to suggest that its new lead product MRX34 is an effective means of tumor suppression.
http://www.swbiosearch.com/2013/01/23/austin-texas-biotech-company-mirna-thereaputics-to-present-preclinical-data-for-cancer-treatment-at-keystone-conference/
Subscribe to:
Posts (Atom)